Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Skin Testing with XOLAIR
NCT00777764Phase 4Completed
- Sponsor
- Genentech
- Start
- Aug 2008
- Primary completion
- Apr 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of omalizumab in allergic asthma, sponsored by Genentech. Started Aug 2008; status: completed.
02
Drugs
omalizumab
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00777764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00777764.